Author

Matthias Ulrich Kassack

Heinrich Heine University DüsseldorfORCID 0000-0002-9094-8481Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Elvira Mukinovic· 1 shared Gerhard FritziD· 1 shared Julia Mann· 1 shared Larissa Messling· 1 shared Lena Abbey· 1 shared Marlena Sekeres· 1 shared Sina Federmann· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Elvira Mukinovic

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintApr 23, 2025

Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil-mediated promotion of DNA damage-driven cell death

Elvira Mukinovic, Sina Federmann, Larissa Messling…·Gerhard Fritz

This study identifies verapamil as a synergistic agent to overcome doxorubicin resistance in ovarian cancer cells by enhancing DNA damage and apoptosis.

DOI 10.1101/2025.04.23.650268

humanbulk RNA-seq

𝕏 PostBluesky